1. Home
  2. SNSE vs ABTS Comparison

SNSE vs ABTS Comparison

Compare SNSE & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • ABTS
  • Stock Information
  • Founded
  • SNSE 2005
  • ABTS 2010
  • Country
  • SNSE United States
  • ABTS Hong Kong
  • Employees
  • SNSE N/A
  • ABTS N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • SNSE Health Care
  • ABTS Technology
  • Exchange
  • SNSE Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • SNSE 9.3M
  • ABTS 9.8M
  • IPO Year
  • SNSE 2021
  • ABTS N/A
  • Fundamental
  • Price
  • SNSE $8.69
  • ABTS $4.03
  • Analyst Decision
  • SNSE Strong Buy
  • ABTS
  • Analyst Count
  • SNSE 3
  • ABTS 0
  • Target Price
  • SNSE $86.67
  • ABTS N/A
  • AVG Volume (30 Days)
  • SNSE 12.2K
  • ABTS 36.3K
  • Earning Date
  • SNSE 08-05-2025
  • ABTS 08-16-2025
  • Dividend Yield
  • SNSE N/A
  • ABTS N/A
  • EPS Growth
  • SNSE N/A
  • ABTS N/A
  • EPS
  • SNSE N/A
  • ABTS N/A
  • Revenue
  • SNSE N/A
  • ABTS $6,711,225.00
  • Revenue This Year
  • SNSE N/A
  • ABTS N/A
  • Revenue Next Year
  • SNSE N/A
  • ABTS N/A
  • P/E Ratio
  • SNSE N/A
  • ABTS N/A
  • Revenue Growth
  • SNSE N/A
  • ABTS 299.11
  • 52 Week Low
  • SNSE $5.00
  • ABTS $1.35
  • 52 Week High
  • SNSE $17.40
  • ABTS $14.10
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 63.87
  • ABTS 49.53
  • Support Level
  • SNSE $5.86
  • ABTS $3.06
  • Resistance Level
  • SNSE $8.74
  • ABTS $4.62
  • Average True Range (ATR)
  • SNSE 0.75
  • ABTS 0.43
  • MACD
  • SNSE 0.25
  • ABTS -0.11
  • Stochastic Oscillator
  • SNSE 88.54
  • ABTS 45.55

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.

Share on Social Networks: